Our Current Trials

Home Current Trials

Our Current Trials

A new clinical trial will begin in February 2022 in the north of the United Kingdom.

The Study Drug is an investigational drug being developed, with an aim to help people in the future with inflammatory diseases including systematic lupus erythematosus (SLE), steroid-refractory graft versus host disease (GvHD), and ulcerative colitis.

The current treatments for these conditions have multiple side effects, and it is hoped that the Study Drug will be more effective and have fewer side effects.

As of 22 September 2020, approximately 136 people have received the Study Drug in research studies at doses up 3000 µg.

Approximately 32 participants will be participating in this study.

The aims of this study are to determine:

  • How much of the Study Drug gets into the bloodstream in Chinese and Japanese participants compared to Caucasian participants?
  • The safety of the Study Drug and any side effects that might be associated with it in Chinese and Japanese participants compared to Caucasian participants.

This study is for research purposes only and is not intended to treat any medical conditions. 

You are not likely to receive any direct benefit from taking part in the study, other than a general assessment of your current overall health. However, the knowledge gained from the study may benefit patients in the future.

Information About Our Current Trials

Study Design
  • Screening visit
  • Inpatient 3 nights 4 days
  • Outpatient visits x8
  • Final Follow up
Study Payment:
  • £3,400
  • Travel and accommodation support available.
  • Must be Chinese
    Males and females in good health,
    Age 20 and 55 years
    Non-smoker tobacco- or nicotine-containing products within 6 months prior to Check-in.
    BMI 17 and 30 kg/m2

Study Dates

Dosage Form

The dose will be given as a subcutaneous (SC) injection. This means that the Study Drug will be injected under your skin, into the fatty tissue above your muscle, in your lower abdomen (belly).

Support Details

-Overnight accommodation provided in Leeds during the clinical trial
-Transportation expenses to the clinical trial facility
-Other supports are available. Contact us for details.

Information About Study Dates

* Please note that the schedule is subject to change
* Compensation would be paid in the form of a cheque or by BACS
Refer-a-Friend Programme Please let us know if you refer a friend who may be interested in joining with you to participate to the end. Please share the clinical trial summary with your friends and tell them to register on our website at www.chinesemedicalresearch.com. Please make sure they fill in your name in the Referrer section when they register.
Please contact us if you are interested in this clinical trial.
We are looking forward to your application.